Izrael -
hebrejština -
Ministry of Health
אייבו % 2 לילדים
abic marketing ltd, israel - ibuprofen - תרחיף - ibuprofen 100 mg / 5 ml - ibuprofen
Izrael -
hebrejština -
Ministry of Health
קובאלטרי iu 1000
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 1000 iu - coagulation factor viii
Izrael -
hebrejština -
Ministry of Health
קובאלטרי iu 2000
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 2000 iu - coagulation factor viii
Izrael -
hebrejština -
Ministry of Health
קובאלטרי iu 250
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 250 iu - coagulation factor viii
Izrael -
hebrejština -
Ministry of Health
קובאלטרי iu 500
bayer israel ltd - recombinant human coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - recombinant human coagulation factor viii 500 iu - coagulation factor viii
Izrael -
hebrejština -
Ministry of Health
פמה-סול 25 מגמל
teva israel ltd - pemetrexed as diacid monohydrate - תרכיז להכנת תמיסה לאינפוזיה - pemetrexed as diacid monohydrate 25 mg / 1 ml - pemetrexed
Izrael -
hebrejština -
Ministry of Health
טייקרב
novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.
Izrael -
hebrejština -
Ministry of Health
מרכך ומסיר עור מהציפורן
ד.מ.מ. סוכנויות ומפיצים בעמ - מרכך מסיר עור מהציפורן